Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Heart Failure | Research

Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study

Authors: Emily L. Graul, Clementine Nordon, Kirsty Rhodes, Shruti Menon, Mahmoud Al Ammouri, Constantinos Kallis, Anne E. Ioannides, Hannah R. Whittaker, Nicholas S. Peters, Jennifer K. Quint

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

An immediate, temporal risk of heart failure and arrhythmias after a Chronic Obstructive Pulmonary Disease (COPD) exacerbation has been demonstrated, particularly in the first month post-exacerbation. However, the clinical profile of patients who develop heart failure (HF) or atrial fibrillation/flutter (AF) following exacerbation is unclear. Therefore we examined factors associated with people being hospitalized for HF or AF, respectively, following a COPD exacerbation.

Methods

We conducted two nested case-control studies, using primary care electronic healthcare records from the Clinical Practice Research Datalink Aurum linked to Hospital Episode Statistics, Office for National Statistics for mortality, and socioeconomic data (2014-2020). Cases had hospitalization for HF or AF within 30 days of a COPD exacerbation, with controls matched by GP practice (HF 2:1;AF 3:1). We used conditional logistic regression to explore demographic and clinical factors associated with HF and AF hospitalization.

Results

Odds of HF hospitalization (1,569 cases, 3,138 controls) increased with age, type II diabetes, obesity, HF and arrhythmia history, exacerbation severity (hospitalization), most cardiovascular medications, GOLD airflow obstruction, MRC dyspnea score, and chronic kidney disease. Strongest associations were for severe exacerbations (adjusted odds ratio (aOR)=6.25, 95%CI 5.10-7.66), prior HF (aOR=2.57, 95%CI 1.73-3.83), age≥80 years (aOR=2.41, 95%CI 1.88-3.09), and prior diuretics prescription (aOR=2.81, 95%CI 2.29-3.45).
Odds of AF hospitalization (841 cases, 2,523 controls) increased with age, male sex, severe exacerbation, arrhythmia and pulmonary hypertension history and most cardiovascular medications. Strongest associations were for severe exacerbations (aOR=5.78, 95%CI 4.45-7.50), age≥80 years (aOR=3.15, 95%CI 2.26-4.40), arrhythmia (aOR=3.55, 95%CI 2.53-4.98), pulmonary hypertension (aOR=3.05, 95%CI 1.21-7.68), and prescription of anticoagulants (aOR=3.81, 95%CI 2.57-5.64), positive inotropes (aOR=2.29, 95%CI 1.41-3.74) and anti-arrhythmic drugs (aOR=2.14, 95%CI 1.10-4.15).

Conclusions

Cardiopulmonary factors were associated with hospitalization for HF in the 30 days following a COPD exacerbation, while only cardiovascular-related factors and exacerbation severity were associated with AF hospitalization. Understanding factors will help target people for prevention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Müllerová H, Marshall J, de Nigris E, Varghese P, Pooley N, Embleton N, et al. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Ther Adv Respir Dis [Internet]. 2022 Jan;16:175346662211136. Available from: https://doi.org/10.1177/17534666221113647. Müllerová H, Marshall J, de Nigris E, Varghese P, Pooley N, Embleton N, et al. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Ther Adv Respir Dis [Internet]. 2022 Jan;16:175346662211136. Available from: https://​doi.​org/​10.​1177/​1753466622111364​7.
3.
go back to reference Balbirsingh V, Mohammed AS, Turner AM, Newnham M. Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review. Thorax [Internet]. 2022 Sep;77(9):939–45. Available from: https://thorax.bmj.com/lookup/doi/https://doi.org/10.1136/thoraxjnl-2021-218333. Balbirsingh V, Mohammed AS, Turner AM, Newnham M. Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review. Thorax [Internet]. 2022 Sep;77(9):939–45. Available from: https://​thorax.​bmj.​com/​lookup/​doi/​https://​doi.​org/​10.​1136/​thoraxjnl-2021-218333.
4.
go back to reference Graul EL, Nordon C, Rhodes K, Marshall J, Menon S, Kallis C, et al. Temporal risk of non-fatal cardiovascular events post COPD exacerbation: a population-based study [Accepted 20 December 2023]. Am J Respir Crit Care Med [Internet]. 2023 Dec; Available from: https://doi.org/10.1164/rccm.202307-1122OC. Graul EL, Nordon C, Rhodes K, Marshall J, Menon S, Kallis C, et al. Temporal risk of non-fatal cardiovascular events post COPD exacerbation: a population-based study [Accepted 20 December 2023]. Am J Respir Crit Care Med [Internet]. 2023 Dec; Available from: https://​doi.​org/​10.​1164/​rccm.​202307-1122OC.
6.
go back to reference Hirayama A, Goto T, Shimada YJ, Faridi MK, Camargo CA, Hasegawa K. Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation. Circ Arrhythm Electrophysiol [Internet]. Sep; 11(9):e006322. Available from: 2018. https://doi.org/10.1161/CIRCEP.118.006322.CrossRef Hirayama A, Goto T, Shimada YJ, Faridi MK, Camargo CA, Hasegawa K. Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation. Circ Arrhythm Electrophysiol [Internet]. Sep; 11(9):e006322. Available from: 2018. https://​doi.​org/​10.​1161/​CIRCEP.​118.​006322.CrossRef
7.
go back to reference Halpin DMG, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial. Lung [Internet]. 2011 Aug [cited 2022 Oct 11];189(4):261–8. Available from: https://doi.org/10.1007/s00408-011-9301-8. Halpin DMG, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial. Lung [Internet]. 2011 Aug [cited 2022 Oct 11];189(4):261–8. Available from: https://​doi.​org/​10.​1007/​s00408-011-9301-8.
9.
go back to reference Swart KMA, Baak BN, Lemmens L, Penning-van Beest FJA, Bengtsson C, Lobier M, Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands. Respir Res [Internet]., et al. 21;24(1):293. Available from: 2023 Nov. https://doi.org/10.1186/s12931-023-02601-4. Swart KMA, Baak BN, Lemmens L, Penning-van Beest FJA, Bengtsson C, Lobier M, Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands. Respir Res [Internet]., et al. 21;24(1):293. Available from: 2023 Nov. https://​doi.​org/​10.​1186/​s12931-023-02601-4.
10.
12.
go back to reference Cuthbert JJ, Pellicori P, Optimal Clark AL., Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges. Int J Gen Med [Internet]. [cited 2023 Aug 9];Volume 15:7961–75. Available from: 2022Oct. https://doi.org/10.2147/IJGM.S295467. Cuthbert JJ, Pellicori P, Optimal Clark AL., Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges. Int J Gen Med [Internet]. [cited 2023 Aug 9];Volume 15:7961–75. Available from: 2022Oct. https://​doi.​org/​10.​2147/​IJGM.​S295467.
15.
go back to reference Kichloo A, Minhas AMK, Jamal S, Shaikh AT, Albosta M, Singh J, Trends and Inpatient Outcomes of Primary Heart Failure Hospitalizations with a Concurrent Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (from The National Inpatient Sample Database from 2004 to 2014). Am J Cardiol [Internet]., et al. Jul; 150:69–76. Available from: 2021. https://doi.org/10.1016/j.amjcard.2021.03.054. Kichloo A, Minhas AMK, Jamal S, Shaikh AT, Albosta M, Singh J, Trends and Inpatient Outcomes of Primary Heart Failure Hospitalizations with a Concurrent Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (from The National Inpatient Sample Database from 2004 to 2014). Am J Cardiol [Internet]., et al. Jul; 150:69–76. Available from: 2021. https://​doi.​org/​10.​1016/​j.​amjcard.​2021.​03.​054.
16.
go back to reference Axson EL, Ragutheeswaran K, Sundaram V, Bloom CI, Bottle A, Cowie MR, Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respir Res [Internet]., et al. [cited 2023 Apr 27];21(1):54. Available from: 2020Dec. https://doi.org/10.1186/s12931-020-1312-7. Axson EL, Ragutheeswaran K, Sundaram V, Bloom CI, Bottle A, Cowie MR, Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respir Res [Internet]., et al. [cited 2023 Apr 27];21(1):54. Available from: 2020Dec. https://​doi.​org/​10.​1186/​s12931-020-1312-7.
17.
go back to reference US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. JAMA [Internet]. 2022 Jan 25;327(4):360. Available from: https://doi.org/10.1001/jama.2021.23732. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. JAMA [Internet]. 2022 Jan 25;327(4):360. Available from: https://​doi.​org/​10.​1001/​jama.​2021.​23732.
18.
go back to reference Abdullah AS, Eigbire G, Ali M, Mohanad A, Abdul W, Hisham I, et al. Relationship of Atrial Fibrillation to Outcomes in Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation. J Atr Fibrillation [Internet]. 2019 Aug [cited 2023 Aug 7];12(2):2117. Available from: https://doi.org/10.4022/jafib.2117. . Abdullah AS, Eigbire G, Ali M, Mohanad A, Abdul W, Hisham I, et al. Relationship of Atrial Fibrillation to Outcomes in Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation. J Atr Fibrillation [Internet]. 2019 Aug [cited 2023 Aug 7];12(2):2117. Available from: https://​doi.​org/​10.​4022/​jafib.​2117. .
19.
go back to reference Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J [Internet]. 2021 Feb 1 [cited 2023 Aug 11];42(5):532–40. Available from: https://doi.org/10.1093/eurheartj/ehaa822. Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J [Internet]. 2021 Feb 1 [cited 2023 Aug 11];42(5):532–40. Available from: https://​doi.​org/​10.​1093/​eurheartj/​ehaa822.
23.
go back to reference Rusinowicz T, Zielonka TM, Zycinska K. Cardiac Arrhythmias in Patients with Exacerbation of COPD. In: Clinical Management of Pulmonary Disorders and Diseases [Internet]. Cham: Springer International Publishing; 2017 [cited 2023 Aug 7]. p. 53–62. (Advances in Experimental Medicine and Biology; vol. 1022). Available from: http://link.springer.com/https://doi.org/10.1007/5584_2017_41. Rusinowicz T, Zielonka TM, Zycinska K. Cardiac Arrhythmias in Patients with Exacerbation of COPD. In: Clinical Management of Pulmonary Disorders and Diseases [Internet]. Cham: Springer International Publishing; 2017 [cited 2023 Aug 7]. p. 53–62. (Advances in Experimental Medicine and Biology; vol. 1022). Available from: http://​link.​springer.​com/​https://​doi.​org/​10.​1007/​5584_​2017_​41.
25.
26.
go back to reference Quint JK, Müllerova H, DiSantostefano RL, Forbes H, Eaton S, Hurst JR, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open [Internet]. 2014 Jul 1;4(7):e005540. Available from: https://doi.org/10.1136/bmjopen-2014-005540. Quint JK, Müllerova H, DiSantostefano RL, Forbes H, Eaton S, Hurst JR, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open [Internet]. 2014 Jul 1;4(7):e005540. Available from: https://​doi.​org/​10.​1136/​bmjopen-2014-005540.
27.
go back to reference Rothnie KJ, Müllerová H, Hurst JR, Smeeth L, Davis K, Thomas SL, et al. Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records. Chotirmall SH, editor. PLOS ONE [Internet]. 2016 Mar 9;11(3):e0151357. Available from: https://doi.org/10.1371/journal.pone.0151357. Rothnie KJ, Müllerová H, Hurst JR, Smeeth L, Davis K, Thomas SL, et al. Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records. Chotirmall SH, editor. PLOS ONE [Internet]. 2016 Mar 9;11(3):e0151357. Available from: https://​doi.​org/​10.​1371/​journal.​pone.​0151357.
28.
go back to reference Rothnie KJ, Müllerová H, Thomas SL, Chandan JS, Smeeth L, Hurst JR, Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. ClinEpidemiol [Internet]., et al. Nov;Volume 8:771–82. Available from: 2016. https://doi.org/10.2147/CLEP.S117867. Rothnie KJ, Müllerová H, Thomas SL, Chandan JS, Smeeth L, Hurst JR, Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. ClinEpidemiol [Internet]., et al. Nov;Volume 8:771–82. Available from: 2016. https://​doi.​org/​10.​2147/​CLEP.​S117867.
30.
go back to reference Graul EL, Stone PW, Massen GM, Hatam S, Adamson A, Denaxas S, et al. Determining prescriptions in electronic healthcare record data: methods for development of standardized, reproducible drug codelists. JAMIA Open [Internet]. 2023 Jul 4 [cited 2023 Sep 1];6(3):ooad078. Available from: https://academic.oup.com/jamiaopen/article/doi/https://doi.org/10.1093/jamiaopen/ooad078/7252957. Graul EL, Stone PW, Massen GM, Hatam S, Adamson A, Denaxas S, et al. Determining prescriptions in electronic healthcare record data: methods for development of standardized, reproducible drug codelists. JAMIA Open [Internet]. 2023 Jul 4 [cited 2023 Sep 1];6(3):ooad078. Available from: https://​academic.​oup.​com/​jamiaopen/​article/​doi/​https://​doi.​org/​10.​1093/​jamiaopen/​ooad078/​7252957.
31.
go back to reference Axson EL, Sundaram V, Bloom CI, Bottle A, Cowie MR, Quint JK. Temporal Trends in the Incidence of Heart Failure among Patients with Chronic Obstructive Pulmonary Disease and Its Association with Mortality. Ann Am Thorac Soc. 2020;17(8):939–48.CrossRefPubMed Axson EL, Sundaram V, Bloom CI, Bottle A, Cowie MR, Quint JK. Temporal Trends in the Incidence of Heart Failure among Patients with Chronic Obstructive Pulmonary Disease and Its Association with Mortality. Ann Am Thorac Soc. 2020;17(8):939–48.CrossRefPubMed
32.
go back to reference de Miguel Díez J, Chancafe Morgan J, Jiménez García R. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis. 2013;8:305–12. de Miguel Díez J, Chancafe Morgan J, Jiménez García R. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis. 2013;8:305–12.
33.
go back to reference Stringer WW. Are We Treating Heart Failure in Patients with Chronic Obstructive Pulmonary Disease Appropriately? Ann Am Thorac Soc. 2020;17(8):932–4.CrossRefPubMedPubMedCentral Stringer WW. Are We Treating Heart Failure in Patients with Chronic Obstructive Pulmonary Disease Appropriately? Ann Am Thorac Soc. 2020;17(8):932–4.CrossRefPubMedPubMedCentral
34.
go back to reference Ehteshami-Afshar S, Mooney L, Dewan P, Desai AS, Lang NN, Lefkowitz MP, Characteristics Clinical, Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF. J Am Heart Assoc [Internet]., et al. 16;10(4):e019238. Available from: 2021Feb. https://doi.org/10.1161/jaha.120.019238. Ehteshami-Afshar S, Mooney L, Dewan P, Desai AS, Lang NN, Lefkowitz MP, Characteristics Clinical, Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF. J Am Heart Assoc [Internet]., et al. 16;10(4):e019238. Available from: 2021Feb. https://​doi.​org/​10.​1161/​jaha.​120.​019238.
35.
go back to reference Mentz RJ, Schmidt PH, Kwasny MJ, Ambrosy AP, O’Connor CM, Konstam MA, et al. The Impact of Chronic Obstructive Pulmonary Disease in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction: An Analysis of the EVEREST Trial. J Card Fail [Internet]. 2012 Jul [cited 2023 Aug 15];18(7):515–23. Available from: https://doi.org/10.1016/j.cardfail.2012.04.010. Mentz RJ, Schmidt PH, Kwasny MJ, Ambrosy AP, O’Connor CM, Konstam MA, et al. The Impact of Chronic Obstructive Pulmonary Disease in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction: An Analysis of the EVEREST Trial. J Card Fail [Internet]. 2012 Jul [cited 2023 Aug 15];18(7):515–23. Available from: https://​doi.​org/​10.​1016/​j.​cardfail.​2012.​04.​010.
36.
go back to reference Mentz RJ, Schulte PJ, Fleg JL, Fiuzat M, Kraus WE, Piña IL, et al. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J [Internet]. 2013 Feb;165(2):193–9. Available from: https://doi.org/10.1016/j.ahj.2012.10.029. Mentz RJ, Schulte PJ, Fleg JL, Fiuzat M, Kraus WE, Piña IL, et al. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J [Internet]. 2013 Feb;165(2):193–9. Available from: https://​doi.​org/​10.​1016/​j.​ahj.​2012.​10.​029.
38.
go back to reference Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation [Internet]. 2016 Feb 2;133(5):484–92. Available from: https://doi.org/10.1161/CIRCULATIONAHA.115.018614. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation [Internet]. 2016 Feb 2;133(5):484–92. Available from: https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​115.​018614.
42.
go back to reference Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, et al. Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol [Internet]. 2007 Apr;18(4):1307–15. Available from: https://doi.org/10.1681/asn.2006101159. Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, et al. Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol [Internet]. 2007 Apr;18(4):1307–15. Available from: https://​doi.​org/​10.​1681/​asn.​2006101159.
43.
go back to reference Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax. 2021 Apr 29;thoraxjnl-2020-216390. Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax. 2021 Apr 29;thoraxjnl-2020-216390.
44.
go back to reference Ioannides AE, Tayal U, Quint JK. Spirometry in atrial fibrillation: what’s the catch? Expert Rev Respir Med. 2023;17(10):937–50.CrossRefPubMed Ioannides AE, Tayal U, Quint JK. Spirometry in atrial fibrillation: what’s the catch? Expert Rev Respir Med. 2023;17(10):937–50.CrossRefPubMed
45.
go back to reference Huang Q, Xiong H, Shuai T, Zhang M, Zhang C, Wang Y, et al. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ [Internet]. 2020 Dec 2;8:e10376. Available from: https://doi.org/10.7717/peerj.10376. Huang Q, Xiong H, Shuai T, Zhang M, Zhang C, Wang Y, et al. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ [Internet]. 2020 Dec 2;8:e10376. Available from: https://​doi.​org/​10.​7717/​peerj.​10376.
48.
go back to reference van der Velden RMJ, Hermans ANL, Pluymaekers NAHA, Gawalko M, Elliott A, Hendriks JM, et al. Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach. Int J Cardiol Heart Vasc. 2022;42: 101086.PubMedPubMedCentral van der Velden RMJ, Hermans ANL, Pluymaekers NAHA, Gawalko M, Elliott A, Hendriks JM, et al. Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach. Int J Cardiol Heart Vasc. 2022;42: 101086.PubMedPubMedCentral
49.
go back to reference Guerra F, Brambatti M, Nieuwlaat R, Marcucci M, Dudink E, Crijns HJGM, et al. Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2017;19(12):1922–9. Guerra F, Brambatti M, Nieuwlaat R, Marcucci M, Dudink E, Crijns HJGM, et al. Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2017;19(12):1922–9.
51.
go back to reference Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax [Internet]. 2021 Aug;76(8):807–14. Available from: https://thorax.bmj.com/lookup/doi/https://doi.org/10.1136/thoraxjnl-2020-216390. Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax [Internet]. 2021 Aug;76(8):807–14. Available from: https://​thorax.​bmj.​com/​lookup/​doi/​https://​doi.​org/​10.​1136/​thoraxjnl-2020-216390.
53.
go back to reference Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2022 May 3;145(18). Available from: https://doi.org/10.1161/CIR.0000000000001063. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2022 May 3;145(18). Available from: https://​doi.​org/​10.​1161/​CIR.​0000000000001063​.
Metadata
Title
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study
Authors
Emily L. Graul
Clementine Nordon
Kirsty Rhodes
Shruti Menon
Mahmoud Al Ammouri
Constantinos Kallis
Anne E. Ioannides
Hannah R. Whittaker
Nicholas S. Peters
Jennifer K. Quint
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-03035-4

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.